The US markets ended marginally lower on Tuesday as New York Governor Andrew Cuomo revealed that coronavirus deaths in his state spiked by 731 on Monday, reflecting the biggest one-day increase. Pharmaceutical stocks showed a significant move to the downside over the course of the session, with the NYSE Arca Pharmaceutical Index slumping by 1.7 percent after ending Monday's trading at its best closing level in nearly a month. However, downside remained capped as traders reacted to recent signs that the spread of the coronavirus is slowing in hot spots such as New York. President Donald Trump expressed optimism during the daily White House coronavirus, saying, there is tremendous light at the end of the tunnel. Trump noted ten potential coronavirus treatments are currently in active trials, with some looking incredibly successful.
On the economic data front, Consumer credit in the US jumped much more than expected in the month of February, according to a report released by the Federal Reserve. The Fed said consumer credit surged up by $22.3 billion in February after climbing by $12.1 billion in January. Street had expected consumer credit to increase by $14.0 billion. The bigger than expected increase came as non-revolving credit, such as student loans and car loans, jumped by $18.1 billion in February after increasing by $14.5 billion in January. Revolving credit, which largely reflects credit card debt, also rose by $4.2 billion in February after dipping by $2.4 billion in the previous month.
Dow Jones Industrial Average declined 26.13 points or 0.12 percent to 22,653.86, Nasdaq lost 25.98 points or 0.33 percent to 7,887.26 and S&P 500 was down by 4.27 points or 0.16 percent to 2,659.41.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: